Compound Detail
CHEMBL1207745
BERAPROST 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2c3cccc(CCCC(=O)O)c3O[C@H]2C[C@H]1O
Basic Information
| ChEMBL ID | CHEMBL1207745 |
| Name | BERAPROST |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | CTPOHARTNNSRSR-APJZLKAGSA-N |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
3
Publications
4
Known Names
2
Indications
Molecular Properties
398.5
MW (Da)
3.29
ALogP
4
HBA
3
HBD
87.0
PSA (Ų)
0.46
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Indications
Renal Insufficiency, Chronic Thrombosis
ATC Classification
B01AC19
beraprost
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: ANTITHROMBOTIC AGENTS
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
Data from ChEMBL 36 via Core Engine